Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals Employee Directory

Biotechnology ResearchMassachusetts, United States1001-5000 Employees

Alnylam Pharmaceuticals, based in Cambridge, Massachusetts, is an independent biopharmaceutical company focused on RNA interference (RNAi) therapeutics. It aims to silence disease-causing genes to treat a range of conditions, including both rare and prevalent diseases, with its first RNAi therapy approved in 2018. The company operates on a global scale with offices across North America, Europe, Asia, and South America and an international workforce. Its products are designed for patients and the healthcare system, and the company pursues partnerships to broaden access, including a June 2026 expansion of its collaboration with Genesis Pharma Group in Europe. Within the biotech industry, Alnylam is positioned as a pioneer in RNAi therapeutics, continuing development across indications and maintaining active engagement in the field.

Find Alnylam Pharmaceuticals employees' phone numbers or email addresses

Alnylam Pharmaceuticals Global Highlights

Location
Employees

North America
2.7K

Minus sign iconPlus sign icon
  • United States Of America
    2.7K
  • Canada
    15
  • Haiti
    1
  • Mexico
    1

Europe
444

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    139
  • Switzerland
    60
  • Netherlands
    58
  • Germany
    55
  • Spain
    37
  • Italy
    35
  • France
    28
  • Portugal
    9
  • Sweden
    7
  • Austria
    7
  • Belgium
    4
  • Greece
    1
  • Ireland
    1
  • Denmark
    1
  • Poland
    1
  • Luxembourg
    1

Asia
64

Minus sign iconPlus sign icon
  • Japan
    43
  • India
    11
  • Saudi Arabia
    6
  • United Arab Emirates
    1
  • Iran
    1
  • China
    1
  • Syrian Arab Republic
    1

South America
29

Minus sign iconPlus sign icon
  • Brazil
    27
  • Paraguay
    1
  • Chile
    1

Africa
3

Minus sign iconPlus sign icon
  • Egypt
    3

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

Alnylam Pharmaceuticals's Leadership

  • Stylized image of a person
    D. C.
    Chief Executive Officer
  • Stylized image of a person
    V. R.
    Chief Financial Officer
  • Stylized image of a person
    D. J.
    Chief Financial Officer
  • Stylized image of a person
    J. H.
    Chief Operating Officer
  • Stylized image of a person
    L. M.
    Chief Of Staff To The Chro And Hr Business Partner
  • Stylized image of a person
    P. H.
    Chief Ethics & Compliance Officer
  • Stylized image of a person
    S. M.
    Chief Development Officer
  • Stylized image of a person
    S. C.
    Chief Technology Officer

Alnylam Pharmaceuticals Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Business
  • Operations
  • Engineering
  • Analytics
  • Other
  • Quality Assurance
  • Biotechnology
  • Sales
  • Legal
  • Administrative
  • Community & Social Services

Contact profiles from Alnylam Pharmaceuticals

Name
Title
Contact
Location
Last Update
  • Stylized image of a person
    T. P.
    Head Of It Operations & Infrastructure, International And Partner & Emerging Markets
    SwitzerlandCanton of Zug
    Aug 30, 2026
  • Stylized image of a person
    L. D.
    Vp, Head Of Medical Affairs, Partner & Emerging Markets
    BrazilSão Paulo
    Apr 21, 2026
  • Stylized image of a person
    G. H.
    Commercial Director, Partner Markets, Central Eastern Europe & Israel
    NetherlandsNorth Holland
    Jul 08, 2026
  • Stylized image of a person
    A. G.
    Legal Director - International Commercial, Rare International And Partner & Emerging Markets
    NetherlandsNorth Holland
    Jul 17, 2026
  • Stylized image of a person
    P. A.
    Business Operations Manager - Partner & Emerging Markets
    United KingdomEngland
    Sep 01, 2026
  • Stylized image of a person
    Y. O.
    President And Representative Director, Alnylam Japan Kk
    JapanTokyo
    Apr 14, 2026
  • Stylized image of a person
    V. R.
    Chief Financial Officer
    IndiaAndhra Pradesh
    Jul 22, 2026
  • Stylized image of a person
    D. J.
    Chief Financial Officer
    Oct 16, 2024
  • Stylized image of a person
    D. C.
    Chief Executive Officer
    Oct 24, 2024
  • Stylized image of a person
    E. R.
    Senior Executive Assistant To Chief Executive Officer
    Oct 18, 2024

Frequently Asked Questions

What is Alnylam Pharmaceuticals known for?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals was founded in 2002 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore Alnylam Pharmaceuticals's company overview page for more information.

What is Alnylam Pharmaceuticals's most common email format?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Alnylam Pharmaceuticals email formats with LeadIQ.

How many employees does Alnylam Pharmaceuticals have currently?

Minus sign iconPlus sign icon
Alnylam Pharmaceuticals has approximately 2.9K employees as of August 2026. These team members are located across 6 continents, including North AmericaEuropeAsia.

Who are Alnylam Pharmaceuticals's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Alnylam Pharmaceuticals's key employees include:

  • Chief Executive Officer: D. C.
  • Chief Financial Officer: V. R.
  • Chief Financial Officer: D. J.
  • Chief Operating Officer: J. H.
  • Chief Of Staff To The Chro And Hr Business Partner: L. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.